SCHEMBL2265629

SCHEMBL2265629

Nc1c(Br)cc(C(O)(c2ccccc2)C(F)(F)F)cc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.39
NR1I2 O75469 1/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 2/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
GAA P10253 3/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
RORC P51449 1/20 0.34
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ATM Q13315 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1813640 0.81 NR1H2 (0.43) NR1H2NR1I2MAPTMEN1KMT2A
SCHEMBL3124978 0.79 GAA (0.34) MAPTMEN1KMT2AGAA
SCHEMBL5865852 0.79 TSHR (0.52) NR1H2NR1I2MAPTMAPK1LMNA
SCHEMBL1815767 0.76 NR1H2 (0.47) NR1H2NR1I2MAPK1ALDH1A1TSHR
SCHEMBL25985492 0.76 NR1H2 (0.47) NR1H2NR1I2MAPK1ALDH1A1TSHR
Hydrochloric Acid SCHEMBL18275180 0.74 NR1H2 (0.46) NR1H2NR1I2MAPK1ALDH1A1TSHR
SCHEMBL1820232 0.74 MAPT (0.42) NR1H2MAPTMEN1KMT2AKDM4E
SCHEMBL24174896 0.74 GAA (0.42) MAPTSMN1; SMN2GAAALDH1A1TSHR
SCHEMBL1815960 0.71 GAA (0.39) MAPTGAAALDH1A1TSHRHPGD
SCHEMBL13736869 0.70 RORC (0.55) NR1H2NR1I2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201603-A1 Novel Acylaminobenzamide Derivatives BAYER CROPSCIENCE AG (DE) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201603-A1 Novel Acylaminobenzamide Derivatives KCNB1, KCNA5, KCNA7 NR1H2 3059/4885NR1I2 1592/4885MAPT 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.